2025 Year in Review

Accelerating Discovery. Expanding Possibility

As the year draws to a close, we’re proud to reflect on an extraordinary 2025, one that marked a pivotal chapter in Scientist.com’s journey and set the stage for an even more impactful future.

This year was defined not only by growth, but by transformation. From our acquisition by GHO Capital Partners to major platform innovations, expansion into clinical research, and continued leadership in AI-driven procurement, 2025 reinforced our commitment to accelerating science through smarter, more connected R&D.

None of this would have been possible without the trust, collaboration, and partnership of our customers, suppliers, and global research community. Below are the milestones that shaped our year and the foundation we’ve built for 2026 and beyond.

A New Chapter with GHO Capital Partners

After 17 years as a privately held company, Scientist.com entered an exciting new era with our acquisition by GHO Capital Partners, a leading global healthcare-focused private equity firm.

This partnership enables accelerated investment in our AI-powered R&D Orchestration Platform, expanded global reach, and deeper support for the life-science ecosystem worldwide, all while preserving the mission and values that have guided us since day one.

You can read more about this milestone in our official announcement, as well as a personal reflection from Co-founder and CEO Kevin Lustig, who shares the company’s journey from inception to acquisition and what lies ahead.

Award-Winning Innovation and Leadership

In 2025, Scientist.com was honored with multiple awards recognizing both platform excellence and individual leadership:

Company Recognition

• Supplier Management Excellence Award – B2B Ecommerce Awards
• Top 50 Healthcare Technology Companies of 2025 – The Healthcare Technology Report

Individual Honors

• Sarah Harkom, General Counsel – Innovation Trailblazer, European Legal Innovation & Technology Awards
• Dan Kagan, President & COO – Top 25 Biotech and Life Sciences Executives of 2025, The Healthcare Technology Report
• Chris Petersen, Co-founder & CTO – 2025 CTO of the Year, 7CTOs

Delivering Measurable Impact: Savings & Efficiency

We continue to innovate with one goal in mind: making research procurement faster, smarter, and more cost-effective. In 2025, our platform helped customers achieve:

• $41+ million in direct cost savings, delivering our clients a competitive advantage
• 190,000+ hours saved through R&D orchestration, freeing up more time to focus on scientific discovery instead of administration

Most-Sourced Research Categories in 2025

While Scientist.com supports a broad range of research needs, the most active categories this year included:

• Human Biological Samples
• Genomics & Protein Sciences
• Toxicology & In Vitro Assays
• Chemistry & Process Development
• Antibodies & Disease Models
• HEOR, Market Access, and Medical Communications

With a Scientist.com account, researchers can access these, and many more, categories through a single, compliant platform.

Tumor Model Finder Surpasses 10,000 Models

Our Tumor Model Finder (TMF) reached a major milestone in 2025, surpassing 10,000 searchable oncology models following a strategic partnership with XenoSTART.

This expansion significantly increases researchers’ access to diverse, clinically relevant tumor models, making it easier than ever to identify the right tools for translational and preclinical research. Read the full press release to learn more.

Bringing R&D Orchestration into Clinical Research

In 2025, we continued our expansion into clinical research with the launch of Clinical Labs Navigator™, a powerful new solution designed to transform how clinical trials are sourced, managed, and executed.

• Streamlined communication
• Fully digitized budgets
• Greater transparency across the clinical research lifecycle

Explore the press release or watch the product demonstration to see it in action.

New Voices: Two New Podcasts Launched

This year, we expanded our thought leadership with the launch of two new podcasts:

Insights & Outcomes, hosted by HealthEconomics.com, hosted by Paige McGarry, Category Manager (Medical/Commercial), this series features conversations with leading experts in HEOR, RWE, and market access on the forces shaping healthcare decision-making.

Biotech Bulls & Breakthroughs, hosted by BioPharmCatalyst and featuring biotech trader Sheff (Sheff Station) and John Gagliano, Director of BioPharmCatalyst, the podcast explores biotech market dynamics, current events, and upcoming catalysts shaping the investment landscape.

Connecting with the Global R&D Community

In 2025, our team traveled extensively to connect with researchers, suppliers, and partners across the globe, strengthening relationships and staying at the forefront of innovation in biotech and pharma.

Planning your year ahead? Check out our recent blog highlighting the must-attend biotech and pharma conferences of 2026.

Looking Ahead to 2026

2025 was a year of meaningful milestones and momentum. As we move into 2026, our mission remains unchanged: to accelerate scientific progress by simplifying, digitizing, and orchestrating global R&D.

We enter the new year with gratitude for our customers, suppliers, partners, and team, and with excitement for what lies ahead.

Thank you for being part of our journey.